Skip to main content

Table 2 Interpahse FISH results of the patients with the TEL-AML1 fusion after complete remission as MRD

From: Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study

  

Clinical course

  

CR1

CR2

CR2, CNS relapse and death

Resistant and death

Total

P

t (12; 21) at Remission (MRD)

Yes

12

2

1

-

15

0.01

 

No

6

9

-

-

15

 

Total

 

18

11

1

-

30

 
  1. FISH was performed to the patients with a positive t(12;21) at the time of diagnosis who passed to remission; a total number of 30 patients. FISH, fluorescence in situ hybridization; CR1, first complete remission; CR2, second complete remission; CNS, involvement of the central nervous system
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us